4-(2-methyl-2-hydroxypropyl-amino)-5,6-dihydrothieno-2(2,3-B)thiopyran-2-sulfonamide-7,7-dioxide
    2.
    发明公开
    4-(2-methyl-2-hydroxypropyl-amino)-5,6-dihydrothieno-2(2,3-B)thiopyran-2-sulfonamide-7,7-dioxide 失效
    4-(2-甲基-2- hydrooxypropylamino)-5,6- dihydrothieno-(2,3- B)噻喃-2-磺酰胺-7,7-二dioxid。

    公开(公告)号:EP0411702A1

    公开(公告)日:1991-02-06

    申请号:EP90202066.8

    申请日:1990-07-27

    申请人: MERCK & CO. INC.

    IPC分类号: C07D495/04 A61K31/38

    CPC分类号: C07D495/04

    摘要: 4-(2-Methyl-2-hydroxypropylamino)-5,6-dihy­drothieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide is a major mammalian metabolite of 4-(2-methylpropyl­amino)-5,6-dihydrothieno[2,3-b]thiopyran-2-sulfon­amide-7,7-dioxide and is itself an active carbonic anhydrase inhibitor useful in the treatment of ocular hypertension by topical administration.

    摘要翻译: 4-(2-甲基-2-羟丙基氨基)-5,6-二氢噻吩并[2,3-b]噻喃-2-磺酰胺-7,7-二氧化物是主要的4-(2-甲基丙基氨基) -5,6-二氢噻吩并[2,3-b]噻喃-2-磺酰胺e-7,7-二氧化物,其本身是用于通过局部给药治疗高眼压症的活性碳酸酐酶抑制剂。